Metropolis introduces AI-powered Allergy Component Testing to help India combat various types of allergies

Mumbai (Maharashtra) [India], May 18 (ANI/SRV): Metropolis Healthcare Limited, India's leading diagnostic service provider, announces the launch of a novel testing platform based on Component Resolved Diagnostics (CRD) to support India's population in diagnosing various forms of allergies

Related Keywords

India ,Mumbai ,Maharashtra ,Surendran Chemmenkotil ,Nilesh Shah ,Metropolis Healthcare Ltd ,World Health Organization ,Metropolis Healthcare ,Facebook ,Twitter ,Linkedin ,Metropolis Healthcare Limited ,Component Resolved Diagnostics ,Artificial Intelligence ,Chief Executive Officer ,Metropoli Allergy ,Allergy Component Testing ,Metropolis Patient App ,Allergy Profile ,South Asia ,Metropolis ,Ntroduces ,Ai Powered ,Allergy ,Component ,Testing ,O ,Help ,Combat ,Arious ,Types ,F ,Allergies ,News ,Ews India ,